Trials / Completed
CompletedNCT03017404
A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection for Patients With Breast Cancer
A Dose Increase Finding Study of Doxorubicin Hydrochloride Liposome Injection in Neoadjuvant Chemotherapy for Patients With Locally Advanced Breast Cancer
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Hebei Medical University Fourth Hospital · Academic / Other
- Sex
- Female
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To study the maximum tolerated dose of Doxorubicin Hydrochloride Liposome Injection combination with cyclophosphamide and sequential treatment of docetaxel for patients with locally advanced breast cancer
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxorubicin Hydrochloride Liposome Injection | |
| DRUG | Cyclophosphamide | |
| DRUG | docetaxel |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2016-05-01
- Completion
- 2016-07-01
- First posted
- 2017-01-11
- Last updated
- 2017-01-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03017404. Inclusion in this directory is not an endorsement.